サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1117398

世界のアジュバント市場：考察と予測 (2028年まで)

Global Adjuvants Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のアジュバント市場：考察と予測 (2028年まで)
出版日: 2022年08月22日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、アジュバント (Adjuvants) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • アジュバントの製品概要
  • 市場：タイプ別
    • 世界のアジュバント 市場規模：タイプ別, 2017 VS 2021 VS 2028
    • Adjuvant Emulsions
    • Pathogen Components
    • Particulate Adjuvants
    • Combination Adjuvants
  • 市場：アプリケーション別
    • 世界のアジュバント 市場規模：アプリケーション別, 2017 VS 2021 VS 2028
    • Farming
    • Veterinary Medicine
    • Medicine
    • Vaccin
    • Others
  • 調査目的
  • 対象期間

第2章 世界のアジュバントの生産

  • 世界のアジュバントの生産能力 (2017-2028)
  • 世界のアジュバントの生産：地域別: 2017 VS 2021 VS 2028
  • 世界のアジュバントの生産：地域別
    • 世界のアジュバントの生産実績：地域別 (2017-2022)
    • 世界のアジュバントの生産予測：地域別 (2023-2028)
  • 北米
  • 欧州
  • 中国
  • 日本

第3章 世界のアジュバントの販売（数量・金額）推定および予測

  • 世界のアジュバントの販売 推定および予測 2017-2028
  • 世界のアジュバントの収益 推定および予測 2017-2028
  • 世界のアジュバントの収益：地域別: 2017 VS 2021 VS 2028
  • 世界のアジュバントの販売：地域別
    • 世界のアジュバントの販売：地域別 (2017-2022)
    • 世界の販売 アジュバント ：地域別 (2023-2028)
  • 世界のアジュバントの収益：地域別
    • 世界のアジュバントの収益：地域別 (2017-2022)
    • 世界のアジュバントの収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第4章 競合：メーカー別

  • 世界のアジュバントの生産能力：メーカー別
  • 世界のアジュバントの販売：メーカー別
    • 世界のアジュバントの販売：メーカー別 (2017-2022)
    • 世界のアジュバントの販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： アジュバント2021
  • 世界のアジュバントの収益：メーカー別
    • 世界のアジュバントの収益：メーカー別 (2017-2022)
    • 世界のアジュバントの収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： アジュバントの収益 2021
  • 世界のアジュバントの販売価格：メーカー別
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のアジュバントの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のアジュバントのメーカーの地理的分布
  • M&A, 拡張計画

第5章 市場規模：タイプ別

  • 世界のアジュバントの販売：タイプ別
    • 世界のアジュバントの販売実績：タイプ別 (2017-2022)
    • 世界のアジュバントの販売予測：タイプ別 (2023-2028)
    • 世界のアジュバントの販売市場シェア：タイプ別 (2017-2028)
  • 世界のアジュバントの収益：タイプ別
    • 世界のアジュバントの収益実績：タイプ別 (2017-2022)
    • 世界のアジュバントの収益予測：タイプ別 (2023-2028)
    • 世界のアジュバントの収益市場シェア：タイプ別 (2017-2028)
  • 世界のアジュバントの価格：タイプ別
    • 世界のアジュバントの価格：タイプ別 (2017-2022)
    • 世界のアジュバントの価格予測：タイプ別 (2023-2028)

第6章 市場規模：アプリケーション別

  • 世界のアジュバントの販売：アプリケーション別
    • 世界のアジュバントの販売実績：アプリケーション別 (2017-2022)
    • 世界のアジュバントの販売予測：アプリケーション別 (2023-2028)
    • 世界のアジュバントの販売市場シェア：アプリケーション別 (2017-2028)
  • 世界のアジュバントの収益：アプリケーション別
    • 世界のアジュバントの収益実績：アプリケーション別 (2017-2022)
    • 世界のアジュバントの収益予測：アプリケーション別 (2023-2028)
    • 世界のアジュバントの収益市場シェア：アプリケーション別 (2017-2028)
  • 世界のアジュバントの価格：アプリケーション別
    • 世界のアジュバントの価格：アプリケーション別 (2017-2022)
    • 世界のアジュバントの価格予測：アプリケーション別 (2023-2028)

第7章 北米

  • 北米のアジュバント 市場規模：タイプ別
    • 北米のアジュバントの販売：タイプ別 (2017-2028)
    • 北米のアジュバントの収益：タイプ別 (2017-2028)
  • 北米のアジュバント 市場規模：アプリケーション別
    • 北米のアジュバントの販売：アプリケーション別 (2017-2028)
    • 北米のアジュバントの収益：アプリケーション別 (2017-2028)
  • 北米のアジュバントの販売：国別
    • 北米のアジュバントの販売：国別 (2017-2028)
    • 北米のアジュバントの収益：国別 (2017-2028)
    • 米国
    • カナダ

第8章 欧州

  • 欧州のアジュバント 市場規模：タイプ別
    • 欧州のアジュバントの販売：タイプ別 (2017-2028)
    • 欧州のアジュバントの収益：タイプ別 (2017-2028)
  • 欧州のアジュバント 市場規模：アプリケーション別
    • 欧州のアジュバントの販売：アプリケーション別 (2017-2028)
    • 欧州のアジュバントの収益：アプリケーション別 (2017-2028)
  • 欧州のアジュバントの販売：国別
    • 欧州のアジュバントの販売：国別 (2017-2028)
    • 欧州のアジュバントの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 アジア太平洋

  • アジア太平洋のアジュバント 市場規模：タイプ別
    • アジア太平洋のアジュバントの販売：タイプ別 (2017-2028)
    • アジア太平洋のアジュバントの収益：タイプ別 (2017-2028)
  • アジア太平洋のアジュバント 市場規模：アプリケーション別
    • アジア太平洋のアジュバントの販売：アプリケーション別 (2017-2028)
    • アジア太平洋のアジュバントの収益：アプリケーション別 (2017-2028)
  • アジア太平洋のアジュバントの販売：地域別
    • アジア太平洋のアジュバントの販売：地域別 (2017-2028)
    • アジア太平洋のアジュバントの収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第10章 ラテンアメリカ

  • ラテンアメリカのアジュバント 市場規模：タイプ別
    • ラテンアメリカのアジュバントの販売：タイプ別 (2017-2028)
    • ラテンアメリカのアジュバントの収益：タイプ別 (2017-2028)
  • ラテンアメリカのアジュバント 市場規模：アプリケーション別
    • ラテンアメリカのアジュバントの販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのアジュバントの収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのアジュバントの販売：国別
    • ラテンアメリカのアジュバントの販売：国別 (2017-2028)
    • ラテンアメリカのアジュバントの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第11章 中東・アフリカ

  • 中東・アフリカのアジュバント 市場規模：タイプ別
    • 中東・アフリカのアジュバントの販売：タイプ別 (2017-2028)
    • 中東・アフリカのアジュバントの収益：タイプ別 (2017-2028)
  • 中東・アフリカのアジュバント 市場規模：アプリケーション別
    • 中東・アフリカのアジュバントの販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのアジュバントの収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのアジュバントの販売：国別
    • 中東・アフリカのアジュバントの販売：国別 (2017-2028)
    • 中東・アフリカのアジュバントの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア
    • UAE

第12章 企業プロファイル

  • BASF
  • Syngenta
  • Bayer CropScience
  • Novozymes
  • Koppert Biological Systems
  • Monsanto
  • Biobest
  • Certis USA
  • Andermatt Biocontrol

第13章 業界チェーンと販売チャネルの分析

  • アジュバント 業界チェーン分析
  • アジュバント 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • アジュバント 生産形態とプロセス
  • アジュバント 販売およびマーケティング
    • アジュバント 販売チャネル
    • アジュバント 卸業者
  • アジュバント 顧客

第14章 市場の促進要因, 機会, 課題とリスク要因の分析

  • アジュバント 業界動向
  • アジュバント 市場の促進要因
  • アジュバント 市場の課題
  • アジュバント 市場の抑制要因

第15章 世界のアジュバントの主な市場調査結果

第16章 付録

図表
  • Table 1. Global Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Adjuvant Emulsions
  • Table 3. Major Manufacturers of Pathogen Components
  • Table 4. Major Manufacturers of Particulate Adjuvants
  • Table 5. Major Manufacturers of Combination Adjuvants
  • Table 6. Global Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
  • Table 7. Global Adjuvants Production by Region: 2017 VS 2021 VS 2028 (K MT)
  • Table 8. Global Adjuvants Production by Region (2017-2022) & (K MT)
  • Table 9. Global Adjuvants Production Market Share by Region (2017-2022)
  • Table 10. Global Adjuvants Production by Region (2023-2028) & (K MT)
  • Table 11. Global Adjuvants Production Market Share by Region (2023-2028)
  • Table 12. Global Adjuvants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 13. Global Adjuvants Sales by Region (2017-2022) & (K MT)
  • Table 14. Global Adjuvants Sales Market Share by Region (2017-2022)
  • Table 15. Global Adjuvants Sales by Region (2023-2028) & (K MT)
  • Table 16. Global Adjuvants Sales Market Share by Region (2023-2028)
  • Table 17. Global Adjuvants Revenue by Region (2017-2022) & (US$ Million)
  • Table 18. Global Adjuvants Revenue Market Share by Region (2017-2022)
  • Table 19. Global Adjuvants Revenue by Region (2023-2028) & (US$ Million)
  • Table 20. Global Adjuvants Revenue Market Share by Region (2023-2028)
  • Table 21. Global Adjuvants Production Capacity by Manufacturers (2017-2022) & (K MT)
  • Table 22. Global Adjuvants Capacity Market Share by Manufacturers (2017-2022)
  • Table 23. Global Adjuvants Sales by Manufacturers (2017-2022) & (K MT)
  • Table 24. Global Adjuvants Sales Market Share by Manufacturers (2017-2022)
  • Table 25. Global Adjuvants Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 26. Global Adjuvants Revenue Share by Manufacturers (2017-2022)
  • Table 27. Adjuvants Price by Manufacturers 2017-2022 (USD/MT)
  • Table 28. Global Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 29. Global Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvants as of 2021)
  • Table 30. Adjuvants Manufacturing Base Distribution and Headquarters
  • Table 31. Manufacturers Adjuvants Product Offered
  • Table 32. Date of Manufacturers Enter into Adjuvants Market
  • Table 33. Mergers & Acquisitions, Expansion Plans
  • Table 34. Global Adjuvants Sales by Type (2017-2022) & (K MT)
  • Table 35. Global Adjuvants Sales by Type (2023-2028) & (K MT)
  • Table 36. Global Adjuvants Sales Share by Type (2017-2022)
  • Table 37. Global Adjuvants Sales Share by Type (2023-2028)
  • Table 38. Global Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 39. Global Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 40. Global Adjuvants Revenue Share by Type (2017-2022)
  • Table 41. Global Adjuvants Revenue Share by Type (2023-2028)
  • Table 42. Adjuvants Price by Type (2017-2022) & (USD/MT)
  • Table 43. Global Adjuvants Price Forecast by Type (2023-2028) & (USD/MT)
  • Table 44. Global Adjuvants Sales by Application (2017-2022) & (K MT)
  • Table 45. Global Adjuvants Sales by Application (2023-2028) & (K MT)
  • Table 46. Global Adjuvants Sales Share by Application (2017-2022)
  • Table 47. Global Adjuvants Sales Share by Application (2023-2028)
  • Table 48. Global Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 49. Global Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 50. Global Adjuvants Revenue Share by Application (2017-2022)
  • Table 51. Global Adjuvants Revenue Share by Application (2023-2028)
  • Table 52. Adjuvants Price by Application (2017-2022) & (USD/MT)
  • Table 53. Global Adjuvants Price Forecast by Application (2023-2028) & (USD/MT)
  • Table 54. North America Adjuvants Sales by Type (2017-2022) & (K MT)
  • Table 55. North America Adjuvants Sales by Type (2023-2028) & (K MT)
  • Table 56. North America Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 57. North America Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 58. North America Adjuvants Sales by Application (2017-2022) & (K MT)
  • Table 59. North America Adjuvants Sales by Application (2023-2028) & (K MT)
  • Table 60. North America Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 61. North America Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 62. North America Adjuvants Sales by Country (2017-2022) & (K MT)
  • Table 63. North America Adjuvants Sales by Country (2023-2028) & (K MT)
  • Table 64. North America Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 65. North America Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 66. Europe Adjuvants Sales by Type (2017-2022) & (K MT)
  • Table 67. Europe Adjuvants Sales by Type (2023-2028) & (K MT)
  • Table 68. Europe Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 69. Europe Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 70. Europe Adjuvants Sales by Application (2017-2022) & (K MT)
  • Table 71. Europe Adjuvants Sales by Application (2023-2028) & (K MT)
  • Table 72. Europe Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 73. Europe Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 74. Europe Adjuvants Sales by Country (2017-2022) & (K MT)
  • Table 75. Europe Adjuvants Sales by Country (2023-2028) & (K MT)
  • Table 76. Europe Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 77. Europe Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Adjuvants Sales by Type (2017-2022) & (K MT)
  • Table 79. Asia Pacific Adjuvants Sales by Type (2023-2028) & (K MT)
  • Table 80. Asia Pacific Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 82. Asia Pacific Adjuvants Sales by Application (2017-2022) & (K MT)
  • Table 83. Asia Pacific Adjuvants Sales by Application (2023-2028) & (K MT)
  • Table 84. Asia Pacific Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 85. Asia Pacific Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 86. Asia Pacific Adjuvants Sales by Region (2017-2022) & (K MT)
  • Table 87. Asia Pacific Adjuvants Sales by Region (2023-2028) & (K MT)
  • Table 88. Asia Pacific Adjuvants Revenue by Region (2017-2022) & (US$ Million)
  • Table 89. Asia Pacific Adjuvants Revenue by Region (2023-2028) & (US$ Million)
  • Table 90. Latin America Adjuvants Sales by Type (2017-2022) & (K MT)
  • Table 91. Latin America Adjuvants Sales by Type (2023-2028) & (K MT)
  • Table 92. Latin America Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 93. Latin America Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 94. Latin America Adjuvants Sales by Application (2017-2022) & (K MT)
  • Table 95. Latin America Adjuvants Sales by Application (2023-2028) & (K MT)
  • Table 96. Latin America Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 97. Latin America Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 98. Latin America Adjuvants Sales by Country (2017-2022) & (K MT)
  • Table 99. Latin America Adjuvants Sales by Country (2023-2028) & (K MT)
  • Table 100. Latin America Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 101. Latin America Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Adjuvants Sales by Type (2017-2022) & (K MT)
  • Table 103. Middle East and Africa Adjuvants Sales by Type (2023-2028) & (K MT)
  • Table 104. Middle East and Africa Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 106. Middle East and Africa Adjuvants Sales by Application (2017-2022) & (K MT)
  • Table 107. Middle East and Africa Adjuvants Sales by Application (2023-2028) & (K MT)
  • Table 108. Middle East and Africa Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 109. Middle East and Africa Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 110. Middle East and Africa Adjuvants Sales by Country (2017-2022) & (K MT)
  • Table 111. Middle East and Africa Adjuvants Sales by Country (2023-2028) & (K MT)
  • Table 112. Middle East and Africa Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 113. Middle East and Africa Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 114. BASF Corporation Information
  • Table 115. BASF Description and Major Businesses
  • Table 116. BASF Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 117. BASF Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 118. BASF Recent Development
  • Table 119. Syngenta Corporation Information
  • Table 120. Syngenta Description and Major Businesses
  • Table 121. Syngenta Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 122. Syngenta Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 123. Syngenta Recent Development
  • Table 124. Bayer CropScience Corporation Information
  • Table 125. Bayer CropScience Description and Major Businesses
  • Table 126. Bayer CropScience Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 127. Bayer CropScience Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 128. Bayer CropScience Recent Development
  • Table 129. Novozymes Corporation Information
  • Table 130. Novozymes Description and Major Businesses
  • Table 131. Novozymes Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 132. Novozymes Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 133. Novozymes Recent Development
  • Table 134. Koppert Biological Systems Corporation Information
  • Table 135. Koppert Biological Systems Description and Major Businesses
  • Table 136. Koppert Biological Systems Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 137. Koppert Biological Systems Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 138. Koppert Biological Systems Recent Development
  • Table 139. Monsanto Corporation Information
  • Table 140. Monsanto Description and Major Businesses
  • Table 141. Monsanto Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 142. Monsanto Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 143. Monsanto Recent Development
  • Table 144. Biobest Corporation Information
  • Table 145. Biobest Description and Major Businesses
  • Table 146. Biobest Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 147. Biobest Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 148. Biobest Recent Development
  • Table 149. Certis USA Corporation Information
  • Table 150. Certis USA Description and Major Businesses
  • Table 151. Certis USA Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 152. Certis USA Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 153. Certis USA Recent Development
  • Table 154. Andermatt Biocontrol Corporation Information
  • Table 155. Andermatt Biocontrol Description and Major Businesses
  • Table 156. Andermatt Biocontrol Adjuvants Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
  • Table 157. Andermatt Biocontrol Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 158. Andermatt Biocontrol Recent Development
  • Table 159. Key Raw Materials Lists
  • Table 160. Raw Materials Key Suppliers Lists
  • Table 161. Adjuvants Distributors List
  • Table 162. Adjuvants Customers List
  • Table 163. Adjuvants Market Trends
  • Table 164. Adjuvants Market Drivers
  • Table 165. Adjuvants Market Challenges
  • Table 166. Adjuvants Market Restraints
  • Table 167. Research Programs/Design for This Report
  • Table 168. Key Data Information from Secondary Sources
  • Table 169. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Adjuvants Product Picture
  • Figure 2. Global Adjuvants Market Share by Type in 2021 & 2028
  • Figure 3. Adjuvant Emulsions Product Picture
  • Figure 4. Pathogen Components Product Picture
  • Figure 5. Particulate Adjuvants Product Picture
  • Figure 6. Combination Adjuvants Product Picture
  • Figure 7. Global Adjuvants Market Share by Application in 2021 & 2028
  • Figure 8. Farming
  • Figure 9. Veterinary Medicine
  • Figure 10. Medicine
  • Figure 11. Vaccin
  • Figure 12. Others
  • Figure 13. Adjuvants Report Years Considered
  • Figure 14. Global Adjuvants Capacity, Production and Utilization (2017-2028) & (K MT)
  • Figure 15. Global Adjuvants Production Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 16. Global Adjuvants Production Market Share by Region (2017-2022)
  • Figure 17. Global Adjuvants Production Market Share by Region (2023-2028)
  • Figure 18. Adjuvants Production Growth Rate in North America (2017-2028) & (K MT)
  • Figure 19. Adjuvants Production Growth Rate in Europe (2017-2028) & (K MT)
  • Figure 20. Adjuvants Production Growth Rate in China (2017-2028) & (K MT)
  • Figure 21. Adjuvants Production Growth Rate in Japan (2017-2028) & (K MT)
  • Figure 22. Global Adjuvants Sales 2017-2028 (K MT)
  • Figure 23. Global Adjuvants Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 24. Global Adjuvants Revenue 2017-2028 (US$ Million)
  • Figure 25. Global Adjuvants Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 26. Global Adjuvants Sales Market Share by Region (2017-2022)
  • Figure 27. Global Adjuvants Sales Market Share by Region (2023-2028)
  • Figure 28. North America Adjuvants Sales YoY (2017-2028) & (K MT)
  • Figure 29. North America Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 30. Europe Adjuvants Sales YoY (2017-2028) & (K MT)
  • Figure 31. Europe Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Adjuvants Sales YoY (2017-2028) & (K MT)
  • Figure 33. Asia-Pacific Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 34. Latin America Adjuvants Sales YoY (2017-2028) & (K MT)
  • Figure 35. Latin America Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 36. Middle East & Africa Adjuvants Sales YoY (2017-2028) & (K MT)
  • Figure 37. Middle East & Africa Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 38. The Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 39. The Top 5 and 10 Largest Manufacturers of Adjuvants in the World: Market Share by Adjuvants Revenue in 2021
  • Figure 40. Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 41. Global Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 42. Global Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 43. Global Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 44. Global Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 45. North America Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 46. North America Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 47. North America Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 48. North America Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 49. North America Adjuvants Sales Share by Country (2017-2028)
  • Figure 50. North America Adjuvants Revenue Share by Country (2017-2028)
  • Figure 51. U.S. Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 52. Canada Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 53. Europe Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 54. Europe Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 55. Europe Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 56. Europe Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 57. Europe Adjuvants Sales Share by Country (2017-2028)
  • Figure 58. Europe Adjuvants Revenue Share by Country (2017-2028)
  • Figure 59. Germany Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 60. France Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 61. U.K. Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 62. Italy Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 63. Russia Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 64. Asia Pacific Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 65. Asia Pacific Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 66. Asia Pacific Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 67. Asia Pacific Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 68. Asia Pacific Adjuvants Sales Share by Region (2017-2028)
  • Figure 69. Asia Pacific Adjuvants Revenue Share by Region (2017-2028)
  • Figure 70. China Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 71. Japan Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 72. South Korea Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 73. India Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 74. Australia Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 75. Taiwan Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 76. Indonesia Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 77. Thailand Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 78. Malaysia Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 79. Philippines Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 80. Latin America Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 81. Latin America Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 82. Latin America Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 83. Latin America Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 84. Latin America Adjuvants Sales Share by Country (2017-2028)
  • Figure 85. Latin America Adjuvants Revenue Share by Country (2017-2028)
  • Figure 86. Mexico Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 87. Brazil Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 88. Argentina Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 89. Middle East and Africa Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 90. Middle East and Africa Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 91. Middle East and Africa Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 92. Middle East and Africa Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 93. Middle East and Africa Adjuvants Sales Share by Country (2017-2028)
  • Figure 94. Middle East and Africa Adjuvants Revenue Share by Country (2017-2028)
  • Figure 95. Turkey Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 96. Saudi Arabia Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 97. UAE Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 98. Adjuvants Value Chain
  • Figure 99. Adjuvants Production Process
  • Figure 100. Channels of Distribution
  • Figure 101. Distributors Profiles
  • Figure 102. Bottom-up and Top-down Approaches for This Report
  • Figure 103. Data Triangulation
  • Figure 104. Key Executives Interviewed
目次

This research report focuses on the Adjuvants Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Adjuvants Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Adjuvants Market Size by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Adjuvant Emulsions
    • 1.2.3 Pathogen Components
    • 1.2.4 Particulate Adjuvants
    • 1.2.5 Combination Adjuvants
  • 1.3 Market by Application
    • 1.3.1 Global Adjuvants Market Size by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Farming
    • 1.3.3 Veterinary Medicine
    • 1.3.4 Medicine
    • 1.3.5 Vaccin
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Adjuvants Production

  • 2.1 Global Adjuvants Production Capacity (2017-2028)
  • 2.2 Global Adjuvants Production by Region: 2017 VS 2021 VS 2028
  • 2.3 Global Adjuvants Production by Region
    • 2.3.1 Global Adjuvants Historic Production by Region (2017-2022)
    • 2.3.2 Global Adjuvants Forecasted Production by Region (2023-2028)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 Japan

3 Global Adjuvants Sales in Volume & Value Estimates and Forecasts

  • 3.1 Global Adjuvants Sales Estimates and Forecasts 2017-2028
  • 3.2 Global Adjuvants Revenue Estimates and Forecasts 2017-2028
  • 3.3 Global Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
  • 3.4 Global Adjuvants Sales by Region
    • 3.4.1 Global Adjuvants Sales by Region (2017-2022)
    • 3.4.2 Global Sales Adjuvants by Region (2023-2028)
  • 3.5 Global Adjuvants Revenue by Region
    • 3.5.1 Global Adjuvants Revenue by Region (2017-2022)
    • 3.5.2 Global Adjuvants Revenue by Region (2023-2028)
  • 3.6 North America
  • 3.7 Europe
  • 3.8 Asia-Pacific
  • 3.9 Latin America
  • 3.10 Middle East & Africa

4 Competition by Manufactures

  • 4.1 Global Adjuvants Production Capacity by Manufacturers
  • 4.2 Global Adjuvants Sales by Manufacturers
    • 4.2.1 Global Adjuvants Sales by Manufacturers (2017-2022)
    • 4.2.2 Global Adjuvants Sales Market Share by Manufacturers (2017-2022)
    • 4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Adjuvants in 2021
  • 4.3 Global Adjuvants Revenue by Manufacturers
    • 4.3.1 Global Adjuvants Revenue by Manufacturers (2017-2022)
    • 4.3.2 Global Adjuvants Revenue Market Share by Manufacturers (2017-2022)
    • 4.3.3 Global Top 10 and Top 5 Companies by Adjuvants Revenue in 2021
  • 4.4 Global Adjuvants Sales Price by Manufacturers
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.5.3 Global Adjuvants Manufacturers Geographical Distribution
  • 4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Adjuvants Sales by Type
    • 5.1.1 Global Adjuvants Historical Sales by Type (2017-2022)
    • 5.1.2 Global Adjuvants Forecasted Sales by Type (2023-2028)
    • 5.1.3 Global Adjuvants Sales Market Share by Type (2017-2028)
  • 5.2 Global Adjuvants Revenue by Type
    • 5.2.1 Global Adjuvants Historical Revenue by Type (2017-2022)
    • 5.2.2 Global Adjuvants Forecasted Revenue by Type (2023-2028)
    • 5.2.3 Global Adjuvants Revenue Market Share by Type (2017-2028)
  • 5.3 Global Adjuvants Price by Type
    • 5.3.1 Global Adjuvants Price by Type (2017-2022)
    • 5.3.2 Global Adjuvants Price Forecast by Type (2023-2028)

6 Market Size by Application

  • 6.1 Global Adjuvants Sales by Application
    • 6.1.1 Global Adjuvants Historical Sales by Application (2017-2022)
    • 6.1.2 Global Adjuvants Forecasted Sales by Application (2023-2028)
    • 6.1.3 Global Adjuvants Sales Market Share by Application (2017-2028)
  • 6.2 Global Adjuvants Revenue by Application
    • 6.2.1 Global Adjuvants Historical Revenue by Application (2017-2022)
    • 6.2.2 Global Adjuvants Forecasted Revenue by Application (2023-2028)
    • 6.2.3 Global Adjuvants Revenue Market Share by Application (2017-2028)
  • 6.3 Global Adjuvants Price by Application
    • 6.3.1 Global Adjuvants Price by Application (2017-2022)
    • 6.3.2 Global Adjuvants Price Forecast by Application (2023-2028)

7 North America

  • 7.1 North America Adjuvants Market Size by Type
    • 7.1.1 North America Adjuvants Sales by Type (2017-2028)
    • 7.1.2 North America Adjuvants Revenue by Type (2017-2028)
  • 7.2 North America Adjuvants Market Size by Application
    • 7.2.1 North America Adjuvants Sales by Application (2017-2028)
    • 7.2.2 North America Adjuvants Revenue by Application (2017-2028)
  • 7.3 North America Adjuvants Sales by Country
    • 7.3.1 North America Adjuvants Sales by Country (2017-2028)
    • 7.3.2 North America Adjuvants Revenue by Country (2017-2028)
    • 7.3.3 U.S.
    • 7.3.4 Canada

8 Europe

  • 8.1 Europe Adjuvants Market Size by Type
    • 8.1.1 Europe Adjuvants Sales by Type (2017-2028)
    • 8.1.2 Europe Adjuvants Revenue by Type (2017-2028)
  • 8.2 Europe Adjuvants Market Size by Application
    • 8.2.1 Europe Adjuvants Sales by Application (2017-2028)
    • 8.2.2 Europe Adjuvants Revenue by Application (2017-2028)
  • 8.3 Europe Adjuvants Sales by Country
    • 8.3.1 Europe Adjuvants Sales by Country (2017-2028)
    • 8.3.2 Europe Adjuvants Revenue by Country (2017-2028)
    • 8.3.3 Germany
    • 8.3.4 France
    • 8.3.5 U.K.
    • 8.3.6 Italy
    • 8.3.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Adjuvants Market Size by Type
    • 9.1.1 Asia Pacific Adjuvants Sales by Type (2017-2028)
    • 9.1.2 Asia Pacific Adjuvants Revenue by Type (2017-2028)
  • 9.2 Asia Pacific Adjuvants Market Size by Application
    • 9.2.1 Asia Pacific Adjuvants Sales by Application (2017-2028)
    • 9.2.2 Asia Pacific Adjuvants Revenue by Application (2017-2028)
  • 9.3 Asia Pacific Adjuvants Sales by Region
    • 9.3.1 Asia Pacific Adjuvants Sales by Region (2017-2028)
    • 9.3.2 Asia Pacific Adjuvants Revenue by Region (2017-2028)
    • 9.3.3 China
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 India
    • 9.3.7 Australia
    • 9.3.8 Taiwan
    • 9.3.9 Indonesia
    • 9.3.10 Thailand
    • 9.3.11 Malaysia
    • 9.3.12 Philippines

10 Latin America

  • 10.1 Latin America Adjuvants Market Size by Type
    • 10.1.1 Latin America Adjuvants Sales by Type (2017-2028)
    • 10.1.2 Latin America Adjuvants Revenue by Type (2017-2028)
  • 10.2 Latin America Adjuvants Market Size by Application
    • 10.2.1 Latin America Adjuvants Sales by Application (2017-2028)
    • 10.2.2 Latin America Adjuvants Revenue by Application (2017-2028)
  • 10.3 Latin America Adjuvants Sales by Country
    • 10.3.1 Latin America Adjuvants Sales by Country (2017-2028)
    • 10.3.2 Latin America Adjuvants Revenue by Country (2017-2028)
    • 10.3.3 Mexico
    • 10.3.4 Brazil
    • 10.3.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Adjuvants Market Size by Type
    • 11.1.1 Middle East and Africa Adjuvants Sales by Type (2017-2028)
    • 11.1.2 Middle East and Africa Adjuvants Revenue by Type (2017-2028)
  • 11.2 Middle East and Africa Adjuvants Market Size by Application
    • 11.2.1 Middle East and Africa Adjuvants Sales by Application (2017-2028)
    • 11.2.2 Middle East and Africa Adjuvants Revenue by Application (2017-2028)
  • 11.3 Middle East and Africa Adjuvants Sales by Country
    • 11.3.1 Middle East and Africa Adjuvants Sales by Country (2017-2028)
    • 11.3.2 Middle East and Africa Adjuvants Revenue by Country (2017-2028)
    • 11.3.3 Turkey
    • 11.3.4 Saudi Arabia
    • 11.3.5 UAE

12 Corporate Profiles

  • 12.1 BASF
    • 12.1.1 BASF Corporation Information
    • 12.1.2 BASF Overview
    • 12.1.3 BASF Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.1.4 BASF Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 BASF Recent Developments
  • 12.2 Syngenta
    • 12.2.1 Syngenta Corporation Information
    • 12.2.2 Syngenta Overview
    • 12.2.3 Syngenta Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.2.4 Syngenta Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Syngenta Recent Developments
  • 12.3 Bayer CropScience
    • 12.3.1 Bayer CropScience Corporation Information
    • 12.3.2 Bayer CropScience Overview
    • 12.3.3 Bayer CropScience Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.3.4 Bayer CropScience Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 Bayer CropScience Recent Developments
  • 12.4 Novozymes
    • 12.4.1 Novozymes Corporation Information
    • 12.4.2 Novozymes Overview
    • 12.4.3 Novozymes Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.4.4 Novozymes Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 Novozymes Recent Developments
  • 12.5 Koppert Biological Systems
    • 12.5.1 Koppert Biological Systems Corporation Information
    • 12.5.2 Koppert Biological Systems Overview
    • 12.5.3 Koppert Biological Systems Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.5.4 Koppert Biological Systems Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Koppert Biological Systems Recent Developments
  • 12.6 Monsanto
    • 12.6.1 Monsanto Corporation Information
    • 12.6.2 Monsanto Overview
    • 12.6.3 Monsanto Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.6.4 Monsanto Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.6.5 Monsanto Recent Developments
  • 12.7 Biobest
    • 12.7.1 Biobest Corporation Information
    • 12.7.2 Biobest Overview
    • 12.7.3 Biobest Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.7.4 Biobest Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.7.5 Biobest Recent Developments
  • 12.8 Certis USA
    • 12.8.1 Certis USA Corporation Information
    • 12.8.2 Certis USA Overview
    • 12.8.3 Certis USA Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.8.4 Certis USA Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.8.5 Certis USA Recent Developments
  • 12.9 Andermatt Biocontrol
    • 12.9.1 Andermatt Biocontrol Corporation Information
    • 12.9.2 Andermatt Biocontrol Overview
    • 12.9.3 Andermatt Biocontrol Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 12.9.4 Andermatt Biocontrol Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.9.5 Andermatt Biocontrol Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Adjuvants Industry Chain Analysis
  • 13.2 Adjuvants Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Adjuvants Production Mode & Process
  • 13.4 Adjuvants Sales and Marketing
    • 13.4.1 Adjuvants Sales Channels
    • 13.4.2 Adjuvants Distributors
  • 13.5 Adjuvants Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 14.1 Adjuvants Industry Trends
  • 14.2 Adjuvants Market Drivers
  • 14.3 Adjuvants Market Challenges
  • 14.4 Adjuvants Market Restraints

15 Key Finding in The Global Adjuvants Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer